Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses
- 1 February 2000
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 148 (2) , 387-396
- https://doi.org/10.1016/s0021-9150(99)00267-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- LDL particle size in subjects with previously unsuspected coronary heart disease: relationship with other cardiovascular risk markersAtherosclerosis, 1996
- Inhibitory Effect of Fish Oil N-3 Polyunsaturated Fatty Acids on the Expression of Endothelial Cell Adhesion MoleculesBiochemical and Biophysical Research Communications, 1996
- Predominance of Large LDL and Reduced HDL 2 Cholesterol in Normolipidemic Men With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Differential effects of eicosapentaenoic acid on glycerolipid and apolipoprotein B metabolism in primary human hepatocytes compared to HepG2 cells and primary rat hepatocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interactionAtherosclerosis, 1995
- Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liverJournal of Inherited Metabolic Disease, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987